drugset / Trial / NCT06478940

3Mixtatin and MTA Vital Pulpotomy in Primary Molars

NCT06478940

Phase 1 Unknown 50 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to evaluate clinical and radiographic success of using 3Mixtain versus mineral trioxide aggregate in pulpotomy of deeply carious Primary molars.

Timeline

Start
2024-08-01
Primary completion
2025-08-01
Completion
2025-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefixime Other / unclassified
Subject Ciprofloxacin Small molecule
Subject Metronidazole Small molecule
Subject Simvastatin Small molecule

Indications